Clinical Report: Evolving Clinicopathological Features of Thyroid Carcinoma

Overview

This study analyzes the clinicopathological features of thyroid carcinoma over 20 years, highlighting trends in management and the development of a nomogram for predicting central lymph node metastasis in T1 papillary thyroid carcinoma. Key findings include a significant increase in central lymph node dissection rates and a decrease in central lymph node metastasis rates.

Background

Thyroid cancer is increasingly prevalent, now ranking as the 7th most common cancer in China and the 3rd among women. Papillary thyroid carcinoma, which constitutes over 90% of thyroid cancers, is typically associated with a favorable prognosis, yet lymph node metastasis remains a critical concern due to its association with poorer outcomes. Understanding the evolving management strategies is essential for optimizing patient care.

Data Highlights

Key Findings

• The proportion of thyroid cancer diagnoses increased to 99.3% by 2018.
• Central lymph node dissection rates rose from 34.4% to 97% over the study period.
• Central lymph node metastasis rates decreased from 81.8% to 55%.
• Independent risk factors for central lymph node metastasis included younger age, male sex, larger maximum tumor diameter, multifocality, lymphovascular invasion, and capsule invasion.
• The optimal maximum tumor diameter cutoff for predicting central lymph node metastasis was identified as 0.75 cm.
• The nomogram developed showed a C-index of 0.715, indicating good discrimination for risk stratification.

Clinical Implications

The findings underscore the importance of standardized surgical practices in managing thyroid carcinoma, particularly regarding central lymph node dissection. The nomogram developed can aid clinicians in risk stratification and personalized follow-up strategies for patients with T1-stage papillary thyroid carcinoma.

Conclusion

This comprehensive analysis highlights significant changes in the management of thyroid carcinoma over two decades, emphasizing the need for individualized treatment approaches based on evolving clinical data.

References

1. Expert Commentary: The Importance of Lymph Node Ratio and Ki-67 Levels in Papillary Thyroid Carcinoma, Springer, 2021 -- https://link.springer.com/article/10.1007/s00268-021-06087-3
2. Association of Multifocal Papillary Thyroid Cancer and Hashimoto's Thyroiditis with Increased Risk of Lymph Node Metastasis, Springer, 2013 -- https://link.springer.com/article/10.1007/s00423-013-1158-2
3. Assessing Risk Factors in Thyroid Cancer: The Complex Role of Pathologists, The Journal of Clinical Endocrinology & Metabolism, 2021 -- https://academic.oup.com/jcem/article/110/2/e546/7679824
4. Long-term Surgical Outcomes and Prognostic Indicators in Differentiated Thyroid Carcinoma: A Two-Decade Review, Springer, 2011 -- https://link.springer.com/article/10.1007/s00423-011-0899-z
5. New ATA Management Guidelines for Adult Patients with Differentiated Thyroid Cancer, American Thyroid Association -- https://www.thyroid.org/new-ata-guidelines-adult-patients-differentiated-thyroid-cancer/
6. Toward Dynamic and De-escalated Care: Insights from the ATA 2025 DTC Guidelines, PMC -- https://pmc.ncbi.nlm.nih.gov/articles/PMC13040591/?utm_source=openai
7. Nodal metastases in papillary thyroid microcarcinoma: prevalence and risk factors in 311 patients, Springer, 2025 -- https://link.springer.com/article/10.1007/s00428-025-04312-1?utm_source=openai
8. Expert Commentary: The Importance of Lymph Node Ratio and Ki-67 Levels in Papillary Thyroid Carcinoma
9. Association of Multifocal Papillary Thyroid Cancer and Hashimoto's Thyroiditis with Increased Risk of Lymph Node Metastasis
10. The Journal of Clinical Endocrinology & Metabolism — Assessing Risk Factors in Thyroid Cancer: The Complex Role of Pathologists
11. Long-term Surgical Outcomes and Prognostic Indicators in Differentiated Thyroid Carcinoma: A Two-Decade Review
12. New ATA Management Guidelines for Adult Patients with Differentiated Thyroid Cancer | American Thyroid Association
13. Toward Dynamic and De-escalated Care: Insights from the ATA 2025 DTC Guidelines - PMC
14. Nodal metastases in papillary thyroid microcarcinoma: prevalence and risk factors in 311 patients | Virchows Archiv | Springer Nature Link